Search Results

Containing any of the words

Only of the type

EASi-HF reduced – A Phase III double-blind, randomised, parallel-group superiority trial to evaluate efficacy and safety of the combined use of oral vicadrostat (BI 690517) and empagliflozin compared with placebo and empagliflozin in participants with symptomatic chronic heart failure (HF: NYHA II-IV) and left ventricular ejection fraction (LVEF) < 40% Drug Clinical Trial

Phase 2, randomized, open-label, controlled study to evaluate the efficacy and safety of rapcabtagene autoleucel versus comparator in participants with severe refractory idiopathic inflammatory myopathies Drug Clinical Trial

A Phase 2, adaptive, randomized, open-label, assessor-blinded active-controlled study to evaluate the efficacy and safety of rapcabtagene autoleucel versus Standard of Care in patients suffering from systemic lupus erythematosus (SLE) with active, refractory lupus nephritis (LN) Drug Clinical Trial

A Phase III double-blind, randomised, placebo-controlled trial to evaluate liver-related clinical outcomes and safety of once weekly injected survodutide in participants with compensated non alcoholic steatohepatitis/metabolic dysfunction associated steatohepatitis (NASH/MASH) cirrhosis Drug Clinical Trial

Impact of an Oxygen-Loaded Sustained-Release Hyaluronic Acid Hydrogel on Periodontal Pocket Depth Reduction and Pain Control: A Split-Mouth Randomized Clinical Trial Drug Clinical Trial

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Of Povetacicept In Adults With Immunoglobulin A Nephropathy (Rainier) Drug Clinical Trial

SFDA Alerts About Error in ‘First Step’ Pregnancy Test Instructions for Use Warnings

Saudi Food and Drug Authority warns from using OneTouch® Verio® IQ blood glucose meter (home use) Warnings

"SFDA" Alerts about a Defect in "hoffrichter” GmbH, Breathing Devices Cables Warnings

Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes Awareness Article